Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00444821 · ClinicalTrials.gov registry record · NA
The (PIVOTAL) Study
A NA study, sponsored by Medtronic Cardiovascular.
- Terminated
- Registry status
- NA
- Development phase
- 728
- Enrollment target
NCT00444821: Clinical Trial NA study, sponsored by Medtronic Cardiovascular.
NCT00444821 is a NA study that was terminated before completion, run by Medtronic Cardiovascular. The registered enrollment target is 728 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (48% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00444821, a NA study, was terminated before completion, sponsored by Medtronic Cardiovascular.
- TERMINATED
- Registry status
- NA
- Development phase
- 728 participants
- Enrollment target
Study Summary
The purpose of this study is to compare endovascular repair using any FDA approved Medtronic AAA Stent Graft System versus surveillance in subjects with smaller abdominal aortic aneurysms (AAA)(4-5CM), with respect to AAA rupture and AAA related deaths.
Interventions
- DEVICE AneuRx AAA stent graft / Talent AAA stent graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 728 participants |
| Start Date | 2005-03 |
| Est. Completion | 2010-01 |
| Phase | NA |
Why NCT00444821 stopped before completion
NCT00444821 is an interventional study that assigns participants to a tested intervention. The registered 728 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (48% lower).
The record links to 0 conditions, and to 1 intervention - of which AneuRx AAA stent graft / Talent AAA stent graft is the first listed.
NCT00444821 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00444821 about?
NCT00444821 is a clinical study titled "The (PIVOTAL) Study". The purpose of this study is to compare endovascular repair using any FDA approved Medtronic AAA Stent Graft System versus surveillance in subjects with smaller abdominal aortic aneurysms (AAA)(4-5CM), with respect to AAA rupture and AAA related deaths.
What is the current status of trial NCT00444821?
This trial is currently terminated. It is a NA study. The enrollment target is 728 participants. The study started on 2005-03. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00444821?
The interventions under investigation include: AneuRx AAA stent graft / Talent AAA stent graft (DEVICE).
Who is sponsoring clinical trial NCT00444821?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00444821's enrollment target sits among peer trials
728 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05065216 · 728 participants · Phase 2
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
- NCT05739123 · 728 participants
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
- NCT06433765 · 728 participants
A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
- NCT06660342 · 728 participants
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia